• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Why have oncology reps been leaving?

Quote
Yes, very demotivated salesforce. Akynzeo's a turd with a small market potential and that's only if managed care and in office dispensing pharmacies are promoting it. Then, Halaven has had no new data (NO, 301 and 305 are NOT new data!!!) in five years. I agree that Lenvima has a promising future (but recall, so did Halaven in 2010-11......the Eisai Oncology leadership couldn't get laid in a whorehouse....always snatching defeat from the jaws of vicotry) but that promising future could be years away. For now it's a compound for the few of us with centers of excellence.
 




anonymous said:
Yes, very demotivated salesforce. Akynzeo's a turd with a small market potential and that's only if managed care and in office dispensing pharmacies are promoting it. Then, Halaven has had no new data (NO, 301 and 305 are NOT new data!!!) in five years. I agree that Lenvima has a promising future (but recall, so did Halaven in 2010-11......the Eisai Oncology leadership couldn't get laid in a whorehouse....always snatching defeat from the jaws of vicotry) but that promising future could be years away. For now it's a compound for the few of us with centers of excellence.
Click to expand...

Eisai is in oncology?
 




anonymous said:
Yes, very demotivated salesforce. Akynzeo's a turd with a small market potential and that's only if managed care and in office dispensing pharmacies are promoting it. Then, Halaven has had no new data (NO, 301 and 305 are NOT new data!!!) in five years. I agree that Lenvima has a promising future (but recall, so did Halaven in 2010-11......the Eisai Oncology leadership couldn't get laid in a whorehouse....always snatching defeat from the jaws of vicotry) but that promising future could be years away. For now it's a compound for the few of us with centers of excellence.
Click to expand...
It's funny, Eisai is the only company I've ever been with where you are not sent regular metrics showing how your district and region are doing compared with the nation. Does anyone know how much Akynzeo was sold in calendar 2015, for instance?
 




anonymous said:
It's funny, Eisai is the only company I've ever been with where you are not sent regular metrics showing how your district and region are doing compared with the nation. Does anyone know how much Akynzeo was sold in calendar 2015, for instance?
Click to expand...

The sad thing is they will screw up lenvima. It's sad bc I had a great district and manager.

To be with a real oncology company now with a REAL IC plan is eye opening. Wow does Eisai pinch the pennies.
 




anonymous said:
The sad thing is they will screw up lenvima. It's sad bc I had a great district and manager.

To be with a real oncology company now with a REAL IC plan is eye opening. Wow does Eisai pinch the pennies.
Click to expand...

Ya, but you never left your house to try and sell anything so they had to pinch pennies to account for that.
 












anonymous said:
Yes, very demotivated salesforce. Akynzeo's a turd with a small market potential and that's only if managed care and in office dispensing pharmacies are promoting it. Then, Halaven has had no new data (NO, 301 and 305 are NOT new data!!!) in five years. I agree that Lenvima has a promising future (but recall, so did Halaven in 2010-11......the Eisai Oncology leadership couldn't get laid in a whorehouse....always snatching defeat from the jaws of vicotry) but that promising future could be years away. For now it's a compound for the few of us with centers of excellence.
Click to expand...

Always predict the worst outcome for Eisai. You'll come out smelling like a rose.
 




anonymous said:
Ya, but you never left your house to try and sell anything so they had to pinch pennies to account for that.
Click to expand...
What a dumb ass, infantile, disreputable comment for some shithead to make. Maybe you sat on your ass at home but plenty of hard working reps still can't make unrealistic goals with no new data or any effective home office support.
Not to mention that only a kiss ass, fucking moron would say anything to try to justify the incredibly cheap ass policies at Eisai.
 








anonymous said:
What a dumb ass, infantile, disreputable comment for some shithead to make. Maybe you sat on your ass at home but plenty of hard working reps still can't make unrealistic goals with no new data or any effective home office support.
Not to mention that only a kiss ass, fucking moron would say anything to try to justify the incredibly cheap ass policies at Eisai.
Click to expand...

you mad brah?
 




































hhc is noble and so is charity work. To force your company employees to participate is not though. It just leads to lies and forgeries in reporting said charity work. Shame
 




Top Bottom
Back
Quote